Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1529674
PUBLISHER: Grand View Research | PRODUCT CODE: 1529674
Chemiluminescence Immunoassay Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Sample Type (Blood, Urine), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Chemiluminescence Immunoassay Market Growth & Trends:
The global chemiluminescence immunoassay market size is expected to reach USD 15.50 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.6% from 2024 to 2030. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.
Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen's QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.
Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.
Chemiluminescence Immunoassay Market Report Highlights:
- Based on product, consumables dominated the market in 2023 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
- In terms of application, the infectious disease segment held the largest share in 2023 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
- By end use, in 2020, the hospitals segment accounted for the largest share in 2023 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
- In North America, the U.S. held the largest share in 2023 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
- Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market
Product Code: GVR-4-68039-152-8
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Chemiluminescence Immunoassay Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Chemiluminescence Immunoassay Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Chemiluminescence Immunoassay Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Chemiluminescence Immunoassay Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Instruments
- 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Automated
- 4.3.2.1. Automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Semi-automated
- 4.3.3.1. Semi-automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Consumables
- 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Software & Services
- 4.5.1. Software & Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Chemiluminescence Immunoassay Market: Sample Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Chemiluminescence Immunoassay Market: Sample Type Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Blood
- 5.3.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Urine
- 5.4.1. Urine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Saliva
- 5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Other Sample Types
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Chemiluminescence Immunoassay Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Chemiluminescence Immunoassay Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Therapeutic Drug Monitoring
- 6.3.1. Therapeutic Drug Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Oncology
- 6.4.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Cardiology
- 6.5.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Endocrinology
- 6.6.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Infectious Disease
- 6.7.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Autoimmune Disease
- 6.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.9. Other Applications
- 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Chemiluminescence Immunoassay Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Chemiluminescence Immunoassay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 7.3. Hospitals
- 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Clinical Laboratories
- 7.4.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Pharmaceutical & Biotechnology Companies
- 7.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Other End Uses
- 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Chemiluminescence Immunoassay Market: Regional Estimates & Trend Analysis
- 8.1. Chemiluminescence Immunoassay Market Share, By Region, 2023 & 2030 (USD Million)
- 8.2. North America
- 8.2.1. North America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. U.S. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Canada Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Mexico Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
- 8.3.2.1. UK Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Germany Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
- 8.3.4.1. France Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Italy Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Spain Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Denmark Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Sweden Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Norway Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Japan Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
- 8.4.3.1. China Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
- 8.4.4.1. India Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Australia
- 8.4.5.1. Australia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. South Korea
- 8.4.6.1. South Korea Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Thailand Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Brazil Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Argentina Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. South Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Saudi Arabia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. UAE Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Kuwait Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Heat Map Analysis
- 9.4. Company Profiles
- 9.4.1. Abbott Laboratories
- 9.4.1.1. Participant's Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Recent Developments/Strategic Initiatives
- 9.4.2. Beckman Coulter Inc.
- 9.4.2.1. Participant's Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Recent Developments/Strategic Initiatives
- 9.4.3. DiaSorin S.p.A.
- 9.4.3.1. Participant's Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Recent Developments/Strategic Initiatives
- 9.4.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 9.4.4.1. Participant's Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Recent Developments/Strategic Initiatives
- 9.4.5. F. Hoffmann-La Roche AG
- 9.4.5.1. Participant's Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Recent Developments/Strategic Initiatives
- 9.4.6. Siemens Healthineers
- 9.4.6.1. Participant's Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Recent Developments/Strategic Initiatives
- 9.4.7. Ortho Clinical Diagnostics
- 9.4.7.1. Participant's Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Recent Developments/Strategic Initiatives
- 9.4.1. Abbott Laboratories
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.